Citations for
1DEE103, KCNC2
Novel KCNC2 variant associated with developmental and epileptic encephalopathy.
Huo L, Wu Q, Yang F, Liu X, Yang Z, Wang H.
Int J Dev Neurosci. Jun;83(4):357-367. doi: 10.1002/jdn.10263. Epub 2023 May 18 2023
2DEE103, KCNC2
Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants
Schwarz N, Seiffert S, Pendziwiat M, Rademacher AV, Brünger T, Hedrich UBS, Augustijn PB, Baier H, Bayat A, Bisulli F, Buono RJ, Bruria BZ, Doyle MG, Guerrini R, Heimer G, Iacomino M, Kearney H, Klein KM, Kousiappa I, Kunz WS, Lerche H, Licchetta L, Lohmann E, Minardi R, McDonald M, Montgomery S, Mulahasanovic L, Oegema R, Ortal B, Papacostas SS, Ragona F, Granata T, Reif PS, Rosenow F, Rothschild A, Scudieri P, Striano P, Tinuper P, Tanteles GA, Vetro A, Zahnert F, Goldberg EM, Zara F, Lal D, May P, Muhle H, Helbig I, Weber Y.
Neurology. May 17;98(20):e2046-e2059. doi: 10.1212/WNL.0000000000200660. Epub 2022 Mar 21. 2022
3DEE103, KCNC2
A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy
Rydzanicz M, Zwoliński P, Gasperowicz P, Pollak A, Kostrzewa G, Walczak A, Konarzewska M, Płoski R.
Am J Med Genet A. Nov;185(11):3384-3389. doi: 10.1002/ajmg.a.62455. Epub 2021 Aug 27. 2021
4DEE103, KCNC2
A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy
Vetri L, Calě F, Vinci M, Amato C, Roccella M, Granata T, Freri E, Solazzi R, Romano V, Elia M
Eur J Med Genet. Apr;63(4):103848. doi: 10.1016/j.ejmg.2020.103848. Epub 2020 Jan 20. 2020